Gary L. Herman, a director and 10% owner of Virpax Pharmaceuticals, filed an initial statement of beneficial ownership with the SEC on July 5, 2024, as per Form 3 requirements. The filing, which is a routine disclosure for individuals in such positions, indicates that currently, no securities are beneficially owned by Herman. The form was signed by attorney-in-fact Vinay Shah on behalf of Gary Herman on July 9, 2024. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 and is a standard procedure for corporate insiders to report their securities holdings.

Gary L. Herman, a director and 10% owner of Virpax Pharmaceuticals, filed an initial statement of beneficial ownership with the SEC on July 5, 2024, as per Form 3 requirements. The filing, which is a routine disclosure for individuals in such positions, indicates that currently, no securities are beneficially owned by Herman. The form was signed by attorney-in-fact Vinay Shah on behalf of Gary Herman on July 9, 2024. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 and is a standard procedure for corporate insiders to report their securities holdings.